Abstract:Editorial Office Translational Pediatrics Submitted Jul 15, 2024. Accepted for publication Jul 25, 2024. Published online Aug 28, 2024. doi: 10.21037/tp-2024-02 Erratum to: Transl Pediatr 2023;12:1926-30. The article (1) entitled "Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients" ( Transl Pediatr 2023;12:1926-30. doi: 10.21037/tp-23-391) unfortunately contained some mistakes in the main text on page 1929. In paragraph 14, the "event-free-survival" should be "overall survival". The OS should be EFS. The data "91%±4.4% (≤2006) versus 88%±4.3% (>2006)" should be "89%±5.1% (≤2006) versus 87%±4.6% (>2006)". The corrected content is presented as below: Survival analyses revealed that there were no significant differences in overall survival after the reassignment being 89%±5.1% (≤2006) versus 94%±3.2% (>2006). The similar trend was observed for EFS showing 89%±5.1% (≤2006) versus 87%±4.6% (>2006). The small increase in OS observed in the group of patients treated >2006 could be due to the better response of a small subset of patients that relapse. The authors apologize for these errors and state that these errors do not change the scientific conclusions of the article in any way. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Erratum: KCNQ2 Encephalopathy and Responsiveness to Pyridoxal-5′-Phosphate

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction To: Digenic Inheritance of SLC12A3 and CLCNKB Genes in a Chinese Girl with Gitelman Syndrome.

Corrigendum to “from Phenotype to Gene: Detecting Disease‐specific Gene Functional Modules Via a Text‐based Human Disease Phenotype Network Construction” [FEBS Lett. 584 (2010) 3635–3643]

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Corrigendum to: Chloro-s-triazenes-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations

Erratum: Flanagan JM, Sheehan V, Linder H, et al. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013;121(16):3237-3245

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Erratum: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Corrigendum: Characteristics of Genetic Variations Associated With Lennox-Gastaut Syndrome in Korean Families

Erratum to maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

Erratum: Carbon Dioxide Level between Nasal High-Frequency Oscillatory Ventilation and Synchronized Nasal Intermittent Positive Pressure Ventilation after Extubation in Neonates: A Cross-over Randomized Controlled Trial

Author Correction: Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects

Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers 2018, 10, 283

Corrigendum For: Levels of Folate Receptor Autoantibodies in Maternal and Cord Blood and Risk of Neural Tube Defects in a Chinese Population, 106:685–695 (10.1002/Bdra.23517)

Erratum: Dlic1 deficiency impairs ciliogenesis of photoreceptors by destabilizing dynein

Corrigendum To: "pkcα/zfp64/csf1 Axis Resets the Tumor Microenvironment and Fuels Anti-Pd1 Resistance in Hepatocellular Carcinoma" [J Hepatol 77 (2022) 163-176].

Correction: Comparison of two families with and without ataxia harboring novel variants in PRKCG

Retraction: Identification of novel SCN5A single nucleotide variants in Brugada syndrome: a territory-wide study from Hong Kong